SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

ImmunityBio is trending as retail investors rally behind the potential for global commercialization and the anticipation of upcoming clinical data, creating a highly volatile environment marked by intense speculation of a short squeeze. The community is focused on the founder's recent communications regarding global expansion efforts, which many interpret as a strategic push to bypass regulatory hurdles and accelerate market entry.

Novavax, Inc. Is a biotechnology company, which engages in the discovery, development, and commercialization of recombinant vaccines. The company was founded in 1987 and is headquartered in Gaithersburg, MD.

Novavax, Inc.

Novavax Inc

Novavax is trending as investors react to a recent earnings report that exceeded revenue expectations through high-margin licensing deals, even as community sentiment remains polarized over executive compensation and the company's long-term commercial strategy. The discourse is heavily focused on whether management's push for new equity-based incentives is justified given the stock's historical performance, while active discussions highlight potential breakthroughs in pipeline candidates and the impact of activist pressure on future corporate governance.

Advanced Micro Devices, Inc. engages in the semiconductor business. Its products include processors, accelerators, graphics, adaptive SoCs, FPGAs, and SOMs, and software, tools, and apps. The firm offers artificial intelligence, industries, workloads, and gaming solutions. The company was founded by W. J. Sanders III on May 1, 1969 and is headquartered in Santa Clara, CA.

Advanced Micro Devices Inc.

Advanced Micro Devices Inc

AMD is trending due to a major earnings beat and raised guidance that triggered a surge in institutional interest and multiple analyst price target upgrades. The community is actively debating whether this represents a sustainable AI-driven structural shift or an overextended bubble, with many traders watching closely for profit-taking signals.

One Stop Systems, Inc. engages in the design, manufacture, and marketing of computing modules and systems targeting edge deployments. It deals with the design and manufacture of high-performance customized computer and flash arrays, in-flight entertainment, and connectivity and value-added reseller with minimal customization. It operates through the OSS and OSS Europe segments. The company was founded by Stephen D. Cooper and Mark Gunn in 1998 and is headquartered in Escondido, CA.

One Stop Systems Inc

One Stop Systems is trending following a strong quarterly earnings report that highlighted significant revenue growth, expanded gross margins, and positive momentum in defense and AI edge-computing sectors. Community discussion is focused on the company's strategic pivot toward ruggedized compute solutions for defense and autonomy, with many investors anticipating long-term re-rating potential fueled by bookings growth and defense contract opportunities.

FuboTV, Inc. is a consumer-first live TV streaming company with the mission of delivering premium sports, news and entertainment programming that offers greater choice, flexibility and value. The company was founded by David Gandler, Alberto Horihuela Suarez, and Sung Ho Choi on February 20, 2009 and is headquartered in New York, NY.

fuboTV Inc - Ordinary Shares - Class A

fuboTV Inc

FuboTV is experiencing heightened volatility and intense debate among retail traders as the community speculates on potential catalysts like NBA sports rights, Disney-backed integration efforts, and upcoming earnings results. While some investors see significant upside potential tied to profitability targets and institutional interest, others are wary due to the stock's history of post-earnings sell-offs and lingering frustration over dilution and management decisions.

Hut 8 Corp. engages in the development and operation of data centers at scale, supporting AI, high-performance computing (HPC), ASIC compute, and other energy-intensive technology applications. It operates through the following segments: Power, Digital Infrastructure, Compute, and Others. The Power segment manages the origination, development, and management of powered land and energy infrastructure. The Digital Infrastructure refers to the development, ownership, and operation of facilities designed to support next-generation, energy-intensive technology application. The Compute segment deals with operating businesses that deploy and monetize compute assets across next-generation energy-intensive technology. The Others segment offers equipment sales and repairs. The company was founded on January 27, 2023 and is headquartered in Miami, FL.

Hut 8 Corp

Hut 8 is currently at the center of investor focus following a massive 15-year, $9.8 billion AI data center lease, which has sparked a strong rerating narrative as the company shifts from a crypto miner to an AI infrastructure leader. While some community members remain skeptical of the transition and the reliance on major hyperscalers, bulls are aggressively highlighting the stock's long-term potential, leading to intense debates over its valuation and recent parabolic price action.

Aurora Innovation, Inc. engages in the design and development of automobile hardware, software, and provision of data services. It offers the Aurora Driver which allows a vehicle to drive itself. The company was founded by Christopher Urmson, Sterling Anderson and James Andrew Bagnell in 2017 and is headquartered in Pittsburgh, PA.

Aurora Innovation Inc - Ordinary Shares - Class A

Aurora Innovation is experiencing significant upward momentum driven by a major partnership expansion with Hirschbach to deploy hundreds of autonomous trucks, signaling a shift from research to large-scale commercialization. Investors are actively discussing the potential for a short squeeze, citing high short interest and massive insider buying that bolsters confidence in the company's long-term scale and execution.

Riot Platforms, Inc. is a bitcoin mining company, which engages in the provision of special cryptocurrency mining computers. It invests in Verady, Coinsquare, and Tess. It operates through the Bitcoin Mining and Engineering segments. The Bitcoin Mining segment focuses on maximizing ability to successfully mine Bitcoin by growing hash rate. The Engineering segment designs and manufactures power distribution equipment and custom engineered electrical products that provides them the ability to vertically integrate many of the critical electrical components and engineering service. The company was founded on July 24, 2000 and is headquartered in Castle Rock, CO.

Riot Platforms Inc

Riot Platforms is surging as investors pivot toward its potential as an AI infrastructure and power-centric datacenter play, bolstered by a significant expansion in its partnership with AMD. Community sentiment is highly active, with traders closely monitoring technical resistance levels while debating the long-term strategic transformation from pure Bitcoin mining into a critical AI power provider.

Joby Aviation, Inc. is a transportation company, which engages in developing an all-electric, vertical take-off and landing aircraft that intends to operate as a commercial passenger aircraft. The company was founded by Bevirt Joebenn in 2009 and is headquartered in Santa Cruz, CA.

Joby Aviation Inc

Joby Aviation is driving significant buzz as the company shifts from developmental milestones to real-world commercial viability, highlighted by high-profile flight demonstrations in New York City and a strong institutional backing. While the community remains divided between long-term investors tracking FAA certification progress and skeptics focused on cash burn and technical hurdles, active discussions are fixated on the upcoming earnings call and the potential for the company to solidify its position as the leader in urban air mobility.

Super Micro Computer, Inc. engages in the distribution and manufacture of information technology solutions and other computer products. Its products include twin solutions, MP servers, GPU and coprocessor, MicroCloud, AMD solutions, power supplies, SuperServer, storage, motherboards, chassis, super workstations, accessories, SuperRack and server management products. The company was founded by Charles Liang, Yih-Shyan Liaw, Sara Liu, and Chiu-Chu Liu Liang in September 1993 and is headquartered in San Jose, CA.

Super Micro Computer Inc

Super Micro Computer is trending as the stock surges following a strong earnings report where improved gross margins and robust future guidance overshadowed a revenue miss. The community is actively debating the stock's potential for a massive short squeeze and long-term re-rating, contrasting the company's valuation against its AI sector peers.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Novavax Q1 2026 Earnings Call Transcript

<ul class="summary-bullets"><li>Its licensing, royalties, and other revenue rose to $97 million in Q1, up from $45 million a year earlier.</li><li>Novavax is targeting a reduction in expenses, aiming for about $325 million in combined research and administrative spending in 2026, and around $225 million in 2027.</li><li>·Q1 net loss came in at $9 million, or a loss of $0.06 per share, significantly narrower than the 0.23 per share estimate.</li></ul>Shares of Novavax (NVAX) rose more than 5% in pre-market trading on Wednesday, as investors welcomed a first-quarter earnings beat powered by a sharp surge in the high-margin licensing and royalty revenue, which more than doubled from a year earlier.Total revenue for the first quarter (Q1) of 2026 fell to $140 million, but came above analysts’ estimates of roughly $81 million, according to Fiscal.ai. Revenue last year was heavily driven by a $603 million in non-cash revenue from closing out two advance purchase agreements for its Nuvaxovid COVID-19 vaccine.Q1 net loss&nbsp;came in at $9 million, or a loss of $0.06 per share, significantly narrower than the 0.23 per share estimate.<h2 class="st-heading-2">Pfizer Deal Highlights Platform Value&nbsp;</h2>The company is increasingly leaning on partnerships and licensing agreements tied to its vaccine technology to fuel growth.In January, Novavax secured $30 million upfront from Pfizer (PFE) upon licensing its Matrix-M adjuvant, with the potential for up to an additional $500 million in development and sales milestones. Novavax also stands to earn mid- to high-single-digit royalties on future product sales using the technology.<h2 class="st-heading-2">NVAX’s Key Growth Engine: Licensing And Royalties&nbsp;</h2>The firm’s strategy is gaining strong traction as its partners begin exploring applications across more than half of the global vaccine and immunotherapy market, which is expected to exceed $100 billion by the early 2030s.Overall, its licensing, royalties, and other revenue rose to $97 million in Q1, up from $45 million a year earlier.<h2 class="st-heading-2">Cost Cuts In Focus Amid Activist Investor Pressure</h2>Last month, activist investor Shah Capital pushed for changes at the vaccine maker, calling on management to cut expenses and consider buying back 10-20 million shares.The company said it is already working to lower costs, aiming for about $325 million in combined research and administrative spending in 2026, and around $225 million in 2027.<h2 class="st-heading-2">NVAX Stock: What Did Retail Traders Say?</h2>Retail sentiment for <a href="https://stocktwits.com/symbol/NVAX">NVAX</a> turned ‘extremely bullish’ from ‘neutral’ a day earlier, amid ‘high’ message volumes.One user highlighted the company’s strong IP and its potential to boost an acquisition.<stembedurl>https://stocktwits.com/ajbski/message/652422923</stembedurl>Another user said, “It’s the only thing that matters,” highlighting a headline talking about the company’s strength in vaccine deals.<stembedurl>https://stocktwits.com/Bodu/message/652421649</stembedurl>The stock has gained 20% so far this year.Read also: <a href="https://stocktwits.com/news-articles/markets/equity/oscr-stock-jumps-profit-surge-retail-bullish/cZQzdxSReaD">OSCR Stock Pops Pre-Market On Record Quarterly Income – Retail Traders Say ‘Still Undervalued’ Even At $30</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

In this photo illustration, a medical syringe is displayed on a screen, and the logo of Novavax in the background. (Photo Illustration by Nikos Pekiaridis/SOPA Images/LightRocket via Getty Images)

Novavax Tops Expectations On High-Margin Deals – Retail Says ‘It’s The Only Thing That Matters’

Total revenue for the first quarter fell to $140 million, but came above analysts’ estimates of roughly $81 million, according to Fiscal.ai data.

NVAX Stock Is Rising Even After A Revenue Collapse – Here’s The Catch

Equity

Are These 5 Biotech Stocks Set to Beat Q1 Earnings Estimates?

ANI Pharmaceuticals, Novavax and three other biotechs show strong Earnings ESP signals, hinting at potential Q1 earnings beat as sector results roll in.

Novavax (NVAX) to Release Earnings on Wednesday

Novavax (NASDAQ:NVAX) will be releasing its Q1 2026 earnings before the market opens on Wednesday, May 6. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2026-5-6-novavax-inc-stock...

Novavax (NVAX) Beats Stock Market Upswing: What Investors Need to Know

Novavax (NVAX) concluded the recent trading session at $8.01, signifying a +1.01% move from its prior day's close.

These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar

Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.

Kura Oncology (KURA) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release

Kura Oncology (KURA) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Novavax to Report First Quarter 2026 Financial Results on May 6, 2026

Novavax to Report First Quarter 2026 Financial Results on May 6, 2026 Novavax to Report First Quarter 2026 Financial Results on May 6, 2026 PR Newswire GAITHERSBURG, Md., April 29, 2026 GAITHERSBURG...

Novavax, Inc. (NVAX) is Attracting Investor Attention: Here is What You Should Know  

Novavax (NVAX) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

Novavax (NVAX) Dips More Than Broader Market: What You Should Know

In the closing of the recent trading day, Novavax (NVAX) stood at $8.15, denoting a -3.55% move from the preceding trading day.

$NVAX Q1 &#39;26 Earnings Results &amp; Recap

• Reported GAAP EPS of -$0.06 down -101.86% YoY
• Reported revenue of $139.51M down -79.07% YoY

Stocktwits

 Q1 '26 Earnings Results & Recap

• Reported GAAP EPS of -$0.06 down -101.86% YoY
• Reported revenue of $139.51M down -79.07% YoY

This account has been verified as an official STOCKTWITS representative.

Verified Account

Stocktwits Earnings

Still early innings

Overdone

Consolidation due before next leg up

Memory stocks have surged over the past year - is the run overdone or still early innings?

Stocktwits Polls

Investors are heavily focused on the company's adjuvant platform, noting new MTA collaborations and multi-decade royalty potential.

Ongoing activist pressure and shareholder frustration regarding executive compensation and leadership effectiveness remain central themes.

Traders are intensely tracking recent financial beat results and comparing revenue guidance against historical management performance.

Market participants are buzzing about a potential squeeze, citing significant short interest and high days-to-cover metrics.

NVAX
Novavax Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest NVAX News

NVAXNovavax Inc